Spero therapeutics pipeline
WebApr 14, 2024 · Spero Therapeutics, Inc is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare diseases Its pipeline product candidates include Tebipenem HBr, SPR720, and SPR206. Featured Stories WebOct 3, 2024 · Following the breakthrough deal with GlaxoSmithKline, Spero is in a comfortable position to advance its pipeline. The $150 million non-performance related …
Spero therapeutics pipeline
Did you know?
WebMar 30, 2024 · Spero Therapeutics, headquartered in Cambridge, Massachusetts, is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing, and … WebSpero Therapeutics (NASDAQ: SPRO) is a global multi-asset clinical-stage biopharmaceutical company that develops a pipeline of antibacterials focused on the …
WebSep 22, 2024 · Spero Therapeutics, headquartered in Cambridge, Massachusetts, is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing novel... WebApr 6, 2024 · This afternoon, Spero Therapeutics released financial results and provided a pipeline update for the fourth quarter and full year 2024. Our press release is available on the Investor page of...
WebOct 16, 2024 · CAMBRIDGE, Mass., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on … WebAug 8, 2024 · Spero Therapeutics Mar 2016 - Present7 years 2 months Cambridge, MA Focused on novel treatments for Gram Negative …
WebSep 22, 2024 · Spero Therapeutics ( NASDAQ:SPRO) is flying high in the pre-market session today after a multitude of positive developments. The company has entered into an exclusive license agreement with GSK for the former’s antibiotic candidate, tebipenem HBr. The late-stage product is targeted for the treatment of complicated urinary tract infections.
WebSep 22, 2024 · Spero Therapeutics, headquartered in Cambridge, Massachusetts, is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing novel treatments for bacterial infections, including multi-drug resistant bacterial infections and rare diseases. dave and busters downtown laWebMar 30, 2024 · Spero Therapeutics, headquartered in Cambridge, Massachusetts, is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing novel... black and decker 14000 btu portable acWebMay 3, 2024 · CAMBRIDGE, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on … dave and busters downtown silver springWebApr 12, 2024 · Spero Therapeutics, Inc is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including... black and decker 1.3 cu ft microwaveWeb1 day ago · Spero Therapeutics, headquartered in Cambridge, Massachusetts, is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing novel... dave and busters drink menu pricesWebPipeline / Posters & Publications Spero's Scientific Exchange Posters and Publications Filter all Publications & Posters Download a complete bibliography from each of our ongoing investigational programs below. Filters Tebipenem HBr SPR720 SPR206 SPR741 Sort by Tebipenem HBR PK/PD black and decker 13 amp circular sawWebPipeline / SPR206 SPR206 Novel Intravenous Product Candidate for Treating MDR Gram-Negative Infections in the Hospital There has been a significant decrease in the number of novel IV antibiotics in development and approved over the past 40 years for the treatment of Gram-negative infections. black and decker 1/4 sheet sander youtube